c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Altered glucose metabolism in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen. Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metabolism, specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate. Glutamine, which is highly transported into proliferating cells, is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metabolism is not well understood. Here we report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs and stimulate cell proliferation, transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells. This leads to upregulation of glutamine catabolism. Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the production of ATP or serves as substrate for glutathione synthesis. The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metabolism, and energy and reactive oxygen species homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [629]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1178–180.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [178]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This was not due to increased protein levels of GLS or c-Myc, which regulates GLS expression”
From Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma (2018) · cites this paper as Gao et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“genes involved in glutamine metabolism appear to be under both the direct and indirect transcriptional control of the MYC protein (32, 33)”
From Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (2009) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“It has long been established that Myc activation upregulates glutamine metabolism [79,80], increasing glutamine flux by upregulating the glutamine transporter (ASCT2) and glutaminase-1, thus increasing glutamine conversion to glutamate [81].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [79]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Self-citationTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Widespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas-Tikhonenko, A., & Mendell, J. T. (2008) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,325
Self-citationYates, J. R., Eng, J. K., McCormack, A. L., & Schieltz, D. (1995) · Analytical Chemistry · doi:10.1021/ac00104a020 · Cited by 1,253
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
Reitzer, L. J., Wice, B. M., & Kennell, D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30124-2 · Cited by 1,240
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018
Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927
MicroRNA Expression Profiling in Prostate Cancer
Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0533 · Cited by 899
Cited by
Items 801–900 of 1,006
Hwang, J. S., Kim, S. G., Shin, T. H., Jang, Y. E., Kwon, D. H., & Lee, G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050997 · Cited by 56
Oncogenes and Tumor Suppressors Regulate Glutamine Metabolism in Cancer Cells
Kim, M., & Kim, H. (2013) · Journal of Cancer Prevention · doi:10.15430/jcp.2013.18.3.221 · Cited by 61
Folmes, C. D. L., Martinez‐Fernandez, A., Faustino, R. S., Yamada, S., Pérez-Terzic, C. M., Nelson, T. J., & Terzic, A. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9431-2 · Cited by 60
Szeliga, M., Bogacińska-Karaś, M., Różycka, A., Hilgier, W., Marquez, J., & Albrecht, J. (2014) · Tumor Biology · doi:10.1007/s13277-013-1247-4 · Cited by 54
Alteration of Mitochondrial Proteome Due to Activation of Notch1 Signaling Pathway
Basak, N. P., Roy, A., & Banerjee, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.519405 · Cited by 55
Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells
Kuo, T.-C., Chen, C.-K., Hua, K., Yu, P., Lee, W.-J., Chen, M.-W., Jeng, Y., Chien, M., Kuo, K.-T., Hsiao, M., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.012 · Cited by 57
Impact of MicroRNAs in the Cellular Response to Hypoxia
Bertero, T., Rezzonico, R., Pottier, N., & Mari, B. P. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.006 · Cited by 61
Chakravarthy, D., Muñoz, A. R., Su, A., Hwang, R. F., Keppler, B. R., Chan, D. E., Halff, G. A., Ghosh, R., & Kumar, A. P. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.057 · Cited by 56
From macrophage to osteoclast – How metabolism determines function and activity
Kubatzky, K. F., Uhle, F., & Eigenbrod, T. (2018) · Cytokine · doi:10.1016/j.cyto.2018.06.013 · Cited by 57
LncRNA XLOC_006390 promotes pancreatic carcinogenesis and glutamate metabolism by stabilizing c-Myc
He, J., Li, F., Zhou, Y., Hou, X., Liu, S., Li, X., Zhang, Y., Jing, X., & Yang, L. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.021 · Cited by 57
Hua, Q., Zhang, B., Xu, G., Wang, L., Wang, H., Lin, Z., Yu, D., Ren, J., Zhang, D., Zhao, L., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02023-w · Cited by 58
miR-129-5p alleviates LPS-induced acute kidney injury via targeting HMGB1/TLRs/NF-kappaB pathway
Huang, X., Hou, X., Chuan, L., Wei, S., Wang, J., Yang, X., & Ru, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107016 · Cited by 47
Zhao, L., Huang, Y., Tian, C., Taylor, L., Curthoys, N., Wang, Y., Vernon, H., & Zheng, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032995 · Cited by 53
MicroRNA‐23b downregulates peroxiredoxin III in human prostate cancer
He, H., Zhu, J., Chen, X.-B., Chen, S.-M., Han, Z., Dai, Q.-S., Ling, X., Fu, X., Lin, Z., Deng, Y.-H., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.003 · Cited by 53
The function of microRNAs, small but potent molecules, in human prostate cancer
Sevli, S., Uzumcu, A., Solak, M., Ittmann, M., & Özen, M. (2010) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2010.21 · Cited by 65
Jiang, H., Favaro, E., Goulbourne, C. N., Rakowska, P. D., Hughes, G. M., Ryadnov, M. G., Fong, L. G., Young, S. G., Ferguson, D. J. P., Harris, A. L., et al. (2014) · Methods · doi:10.1016/j.ymeth.2014.02.012 · Cited by 59
Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas
Kim, I.-J., Quigley, D. A., To, M. D., Pham, P., Lin, K., Jo, B., Jen, K., Raz, D. J., Kim, J. H., Mao, J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2660 · Cited by 56
Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 66
Targeting the glutamine-arginine-proline metabolism axis in cancer
Wang, D., Duan, J., Guo, Y., Chen, J., Chen, T.-Q., Wang, J., & Yu, S. (2024) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2024.2367129 · Cited by 61
TRIM24 links glucose metabolism with transformation of human mammary epithelial cells
Pathiraja, T. N., Thakkar, K. N., Jiang, S., Stratton, S. A., Liu, Z., Gagea, M., Shi, X., Shah, P. K., Phan, L. M., Lee, M.-H., et al. (2014) · Oncogene · doi:10.1038/onc.2014.220 · Cited by 56
Seviour, E. G., Sehgal, V., Lu, Y., Luo, Z., Moss, T. J. M., Zhang, F., Hill, S. M., Liu, W., Maiti, S. N., Cooper, L. J. N., et al. (2015) · Oncogene · doi:10.1038/onc.2014.469 · Cited by 57
Ogawa, T., Washio, J., Takahashi, T., Echigo, S., & Takahashi, N. (2014) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2014.04.003 · Cited by 59
Protein lysine acetylation guards metabolic homeostasis to fight against cancer
Xu, W., Li, Y., LIU, C., & Zhao, S. (2013) · Oncogene · doi:10.1038/onc.2013.163 · Cited by 58
Qie, S., Liang, D., Yin, C., Gu, W., Meng, M., Wang, C., & Sang, N. (2012) · Cell Cycle · doi:10.4161/cc.21944 · Cited by 51
Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma
Dolezal, J. M., Wang, H., Kulkarni, S., Jackson, L. E., Lu, J. L., Ranganathan, S., Goetzman, E. S., Bharathi, S. S., Beezhold, K., Byersdorfer, C. A., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.782052 · Cited by 50
Feist, M., Schwarzfischer, P., Heinrich, P., Sun, X., Kemper, J., von Bonin, F., Pérez-Rubio, P., Taruttis, F., Rehberg, T., Dettmer, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03803-x · Cited by 60
Glutamine metabolism in cancer therapy
Nguyen, T.-L., & Durán, R. V. (2018) · Cancer Drug Resistance · doi:10.20517/cdr.2018.08 · Cited by 66
Tuccitto, A., Shahaj, E., Vergani, E., Ferro, S., Huber, V., Rodolfo, M., Castelli, C., Rivoltini, L., & Vallacchi, V. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2477-z · Cited by 56
The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer
Hon, K. W., Abidin, S. A. Z., Othman, I., & Naidu, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768861 · Cited by 57
Conserved MicroRNAs in Chinese hamster ovary cell lines
Johnson, K. C., Jacob, N. M., Nissom, P. M., Hackl, M., Lee, L. H., Yap, M., & Hu, W. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.22940 · Cited by 50
PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis
Mzoughi, S., Fong, J. Y., Papadopoli, D. J., Koh, C. M., Hulea, L., Pigini, P., Tullio, F. D., Andreacchio, G., Hoppe, M. M., Wollmann, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17064-0 · Cited by 59
N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages
Menga, A., Favia, M., Spera, I., Vegliante, M. C., Gissi, R., Grassi, A., Laera, L., Campanella, A., Gerbino, A., Carrà, G., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051981 · Cited by 61
Qiu, X., Wang, A., Wang, J., Zhang, Z., & Tao, L. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02670-y · Cited by 65
Hypoxia and Metabolism in Cancer
Bensaad, K., & Harris, A. L. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_1 · Cited by 53
Locasale, J. W., Cantley, L. C., & Heiden, M. G. V. (2009) · Nature Biotechnology · doi:10.1038/nbt1009-916 · Cited by 54
MicroRNAs and the Warburg Effect: New Players in an Old Arena
Gao, P., Sun, L., He, X., Cao, Y., & Zhang, H. (2012) · Current Gene Therapy · doi:10.2174/156652312802083620 · Cited by 55
Self-citationLysosomotropism depends on glucose: a chloroquine resistance mechanism
Gallagher, L. E., Radhi, O. A., Abdullah, M. O., McCluskey, A. G., Boyd, M., & Chan, E. Y. W. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.416 · Cited by 58
Discovery and development of small molecule modulators targeting glutamine metabolism
Li, L., Meng, Y., Li, Z., Dai, W., Xu, X., Bi, X., & Bian, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.066 · Cited by 49
MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities
Bisso, A., Sabò, A., & Amati, B. B. (2019) · Immunological Reviews · doi:10.1111/imr.12734 · Cited by 57
Targeting Cell Metabolism as Cancer Therapy
Ngoi, N. Y. L., Eu, J. Q., Hirpara, J. L., Wang, L., Lim, J. S. J., Lee, S. C., Lim, Y., Pervaiz, S., Goh, B. C., & Wong, A. L. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7947 · Cited by 60
Li, X., Quan, P., Si, Y., Liu, F., Fan, Y., Ding, F., Sun, L., Liu, H., Huang, S., Sun, L., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03009-z · Cited by 58
Emerging Roles of MicroRNA-22 in Human Disease and Normal Physiology
Xiong, J. (2012) · Current Molecular Medicine · doi:10.2174/156652412799218886 · Cited by 53
Lin, S., Guo, Q., Wen, J., Li, C., Lin, J., Cui, X., Sang, N., & Pan, J. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-26 · Cited by 50
Long, Y., Tsai, W.-B., Wang, D., Hawke, D. H., Savaraj, N., Feun, L. G., Hung, M., Chen, H. H. W., & Kuo, M. T. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.028 · Cited by 54
Saha, P., & Datta, K. (2018) · Oncotarget · doi:10.18632/oncotarget.24082 · Cited by 49
Immunometabolism: A new target for improving cancer immunotherapy
Guo, C., Chen, S., Liu, W., Ma, Y., Li, J., Fisher, P. B., Fang, X., & Wang, X. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.004 · Cited by 59
Wang, T., Cai, B., Ding, M., Su, Z., Liu, Y., & Shen, L. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.05.014 · Cited by 52
Rajeeve, K., Vollmuth, N., Janaki‐Raman, S., Wulff, T. F., Baluapuri, A., Dejure, F. R., Huber, C., Fink, J., Schmalhofer, M., Schmitz, W., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0762-5 · Cited by 54
Bharadwaj, S., Singh, M. V., Kirtipal, N., & Kang, S. G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.627842 · Cited by 51
Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer
Cohen, A. S., Geng, L., Zhao, P., Fu, A., Schulte, M. L., Graves-Deal, R., Washington, M. K., Berlin, J., Coffey, R. J., & Manning, H. C. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100828 · Cited by 49
MiR-23-TrxR1 as a novel molecular axis in skeletal muscle differentiation
Mercatelli, N., Fittipaldi, S., De Paola, E., Dimauro, I., Paronetto, M. P., Jackson, M. J., & Caporossi, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-07575-0 · Cited by 49
Transporters at the Interface between Cytosolic and Mitochondrial Amino Acid Metabolism
Hewton, K. G., Johal, A. S., & Parker, S. J. (2021) · Metabolites · doi:10.3390/metabo11020112 · Cited by 54
Kelly, P. S., Breen, L., Gallagher, C., Kelly, S., Henry, M., Lao, N. T., Meleady, P., O'Gorman, D., Clynes, M., & Barron, N. (2015) · Biotechnology Journal · doi:10.1002/biot.201500101 · Cited by 49
Differentiation-associated microRNAs antagonize the Rb–E2F pathway to restrict proliferation
Marzi, M. J., Puggioni, E. M. R., Dall’Olio, V., Bucci, G., Bernard, L., Bianchi, F., Crescenzi, M., Fiore, P. P. D., & Nicassio, F. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201206033 · Cited by 57
Novel Therapeutic Targets of Tumor Metabolism
Kishton, R. J., & Rathmell, J. C. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000099 · Cited by 50
Zhu, M., Wang, N., Tsao, S., Yuen, M., Feng, Y., Wan, T. S. K., Man, K., & Feng, Y. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2010.164 · Cited by 50
Bhatia, B., Potts, C. R., Guldal, C. G., Choi, S., Korshunov, A., Pfister, S. M., Kenney, A. M., & Nahle, Z. A. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0968-6 · Cited by 53
MYC-induced metabolic stress and tumorigenesis
Wolpaw, A. J., & Dang, C. V. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.05.003 · Cited by 57
Self-citationRonca, R., Ghedini, G. C., Maccarinelli, F., Sacco, A., Locatelli, S. L., Foglio, E., Taranto, S., Grillo, E., Matarazzo, S., Castelli, R., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2714 · Cited by 52
Grand, M. L., Mukha, A., Püschel, J., Valli, E., Kamili, A., Vittorio, O., Dubrovska, A., & Kavallaris, M. (2020) · Theranostics · doi:10.7150/thno.42602 · Cited by 50
Jiang, K., Jiang, T., Chen, Y., & Mao, X. (2021) · Mediators of Inflammation · doi:10.1155/2021/2979124 · Cited by 51
Lang, L., Wang, F., Ding, Z., Zhao, X., Loveless, R., Xie, J., Shay, C., Qiu, P., Ke, Y., Saba, N. F., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02207-y · Cited by 57
The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis
Huang, T., Ping, Y., Wang, A.-M., Ke, C.-C., Fang, W., Huang, K., Lee, H., Chi, C., & Yeh, T.-S. (2015) · Oncotarget · doi:10.18632/oncotarget.4000 · Cited by 48
Song, J. H., An, N., Chatterjee, S., Kistner-Griffin, E., Mahajan, S., Mehrotra, S., & Kraft, A. S. (2015) · Oncogene · doi:10.1038/onc.2014.306 · Cited by 48
Sun, L.-Y., Wang, N., Ban, T., Sun, Y.-H., Han, Y., Sun, L., Yan, Y., Kang, X., Chen, S., Sun, L., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.06.012 · Cited by 51
MicroRNAs: Potential regulators involved in human anencephaly
Zhang, Z., Chang, H., Li, Y., Zhang, T., Zou, J., Zheng, X., & Wu, J. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.023 · Cited by 53
Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism
de Cedrón, M. G., & de Molina, A. R. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r061812 · Cited by 53
Glutamine at focus: versatile roles in cancer
Vitto, H. D., Pérez-Valencia, J. A., & Radosevich, J. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-4671-9 · Cited by 57
Structural basis for exploring the allosteric inhibition of human kidney type glutaminase
Ramachandran, S., Pan, C. Q., Zimmermann, S. C., Duvall, B., Tsukamoto, T., Low, B. C., & Sivaraman, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10791 · Cited by 47
Wang, D., Meng, G., Zheng, M., Zhang, Y., Chen, A., Wu, J., & Wei, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166423 · Cited by 55
Singh, B., Modica-Napolitano, J. S., & Singh, K. K. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.004 · Cited by 51
Qu, X., Sun, J., Zhang, Y., Li, J., Hu, J., Li, K., Gao, L., & Shen, L. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.069 · Cited by 50
Intricate crosstalk between MYC and non‐coding RNA s regulates hallmarks of cancer
Swier, L. J. Y. M., Dzikiewicz‐Krawczyk, A., Winkle, M., van den Berg, A., & Kluiver, J. L. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12409 · Cited by 55
miR‐145 inhibits glutamine metabolism through c‐myc/GLS1 pathways in ovarian cancer cells
Li, J., Li, X., Wu, L., Pei, M., Li, H., & Jiang, Y. (2019) · Cell Biology International · doi:10.1002/cbin.11182 · Cited by 49
An extended Myc network contributes to glucose homeostasis in cancer and diabetes
Christopher, W. P. (2011) · Frontiers in bioscience · doi:10.2741/3848 · Cited by 53
Mitochondrial Regulation of Macrophage Response Against Pathogens
Choudhuri, S., Chowdhury, I. H., & Garg, N. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.622602 · Cited by 54
Loussouarn, C., Pers, Y., Bony, C., Jørgensen, C., & Noël, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.623973 · Cited by 48
Mechanisms adopted by cancer cells to escape apoptosis–A review
Dandoti, S. S. (2021) · Biocell · doi:10.32604/biocell.2021.013993 · Cited by 61
A role for c-Myc in regulating anti-mycobacterial responses
Yim, H. C. H., Li, J., Pong, J. C. H., & Lau, A. S. Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104892108 · Cited by 47
Ma, H., Weber, G. M., Hostuttler, M. A., Wei, H., Wang, L., & Yao, J. (2015) · BMC Genomics · doi:10.1186/s12864-015-1400-0 · Cited by 56
Regulation of miR-23b expression and its dual role on ROS production and tumour development
Donadelli, M., Dando, I., Fiorini, C., & Palmieri, M. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.04.012 · Cited by 49
Kawano, M., Tanaka, K., Itonaga, I., Iwasaki, T., & Tsumura, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138560 · Cited by 48
Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma
Li, B., He, L., Zuo, D., He, W. A., Wang, Y., Zhang, Y., Liu, W., & Yuan, Y. (2017) · Journal of Cancer · doi:10.7150/jca.17496 · Cited by 49
Shen, L., Qian, C., Cao, H., Wang, Z., Luo, T., & Liang, C. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1535-y · Cited by 50
Metabolomic profiling of hormone-dependent cancers: a bird's eye view
Lloyd, S. M., Arnold, J. M., & Sreekumar, A. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.07.001 · Cited by 55
Mitochondrial Alterations During Carcinogenesis
Wang, X., Peralta, S., & Moraes, C. T. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00004-6 · Cited by 49
Jose, C., Melser, S., Benard, G., & Rossignol, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4357 · Cited by 46
Zeng, J., Huang, X., Zhou, L., Tan, Y., Hu, C., Wang, X., Niu, J., Wang, H., Lin, X., & Yin, P. (2015) · Scientific Reports · doi:10.1038/srep16101 · Cited by 46
Prevention and treatment of cancers by immune modulating nutrients
Janakiram, N. B., Mohammed, A., Madka, V., Kumar, G., & Rao, C. V. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500884 · Cited by 52
Obinata, D., Takayama, K., Takahashi, S., & Inoue, S. (2017) · Cancers · doi:10.3390/cancers9030022 · Cited by 53
JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis
Lynch, J. R., Salik, B., Connerty, P., Vick, B., Leung, H. H. L., Pijning, A. E., Jeremias, I., Spiekermann, K., Trahair, T. N., Liu, T., et al. (2019) · Leukemia · doi:10.1038/s41375-018-0354-z · Cited by 48
Ulanet, D. B., Couto, K., Jha, A., Choe, S., Wang, A., Woo, H.-K., Steadman, M., DeLaBarre, B., Gross, S., Driggers, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115144 · Cited by 45
Surface functionalized biomimetic bioreactors enable the targeted starvation-chemotherapy to glioma
Ke, R., Zhen, X., Wang, H., Li, L., Wang, H., Wang, S., & Xie, X. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.12.009 · Cited by 47
BPTES inhibition of hGA124–551, a truncated form of human kidney-type glutaminase
Hartwick, E. W., & Curthoys, N. P. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.622272 · Cited by 46
O'Shea, J. M., & Ayer, D. E. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014258 · Cited by 47
Emerging tale of UPR and cancer: an essentiality for malignancy
Hazari, Y., Bashir, A., Haq, E. U., & Fazili, K. M. (2016) · Tumor Biology · doi:10.1007/s13277-016-5343-0 · Cited by 53
Zheng, D.-W., Liu, W., Xie, W., Huang, G., Jiang, Q., Yang, Y., Huang, J.-R., Xing, Z., Yuan, M.-L., Wei, M.-N., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00387-1 · Cited by 45
Glutamine metabolism: from proliferating cells to cardiomyocytes
Shen, Y., Zhang, Y., Li, W., Chen, K., Xiang, M., & Ma, H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154778 · Cited by 52
Huang, Z., Chen, Y., Guo, H., & Chen, G. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.630876 · Cited by 51
Lactate-related metabolic reprogramming and immune regulation in colorectal cancer
Sun, Q., Wu, J., Zhu, G., Li, T., Zhu, X., Ni, B., Xu, B., Ma, X., & Li, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1089918 · Cited by 61
Metadata
- Authors
- Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., & Dang, C. V.
- Affiliations
- Johns Hopkins University (US)
- Teikyo University (JP)
- Corresponding author
- Gao, Ping
- Dang, Chi V.
- Venue
- Nature
- Published
- 2009-02-15
- Volume
- 458
- Issue
- 7239
- Pages
- 762-765
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2729443
- OpenAlex
- W2074873270
- Cited by
- 2,124
- References
- 30
- Citations by year
- 2026: 50 · 2025: 85 · 2024: 105 · 2023: 138 · 2022: 131 · 2021: 142 · 2020: 158 · 2019: 146 · 2018: 146 · 2017: 134 · 2016: 126 · 2015: 145 · 2014: 161 · 2013: 125 · 2012: 144
- FWCI
- 37.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- National Institutes of Health (n01hv28180-13-0-0)
- National Heart, Lung, and Blood Institute (N01 HV-28180, N01 HV028180, R01HL085434)
- National Cancer Institute (R01 CA57341, R01CA057341, R01CA120185, P50CA058236, R37CA051497, P50-CA58236, R01CA051497)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- c-Myc, miR-23a, miR-23b, glutamine metabolism, glutaminolysis, microRNA regulation, cancer metabolism, Warburg effect, PC-3 cells, reactive oxygen species, glutathione synthesis
- MeSH terms
- Glutaminase, Glutamine, Humans, Mitochondria, Gene Expression Regulation, Enzymologic, Proto-Oncogene Proteins c-myc, 3' Untranslated Regions, MicroRNAs, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.